Table 3 Combined analysis of EGFR and K-RAS mutation status

From: Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC

 

Primary/metastatic tumour

 
 

wt/wt

wt/mut

mut/wt

mut/mut

Discordance

EGFR

18 (72%)

2 (8%)

4 (16%)

1 (4%)a

7 cases (28%)

K-RAS

17 (68%)

3 (12%)

3 (12%)

2 (8%)

6 cases (24%)

  1. aDel19/Del19 and T790M.
Back to article page